Risk of hypertension and abnormal biomarkers in the first year postpartum associated with hypertensive disorders of pregnancy among overweight and obese women

Alisse Hauspurg, Malamo E. Countouris, Arun Jeyabalan, Carl A. Hubel, James M. Roberts, Eleanor Schwarz, Janet M. Catov

Research output: Contribution to journalArticle

Abstract

Objectives: Hypertension and obesity are common cardiometabolic risk factors in reproductive age women. The association of hypertensive disorders of pregnancy with later-life cardiovascular disease is well-established, however, it is unknown how obesity and hypertensive disorders of pregnancy converge to accelerate development of hypertension in the postpartum period. The aim of this study was to characterize rates of sustained hypertension at one year postpartum using the new American Heart Association/American College of Cardiology Guidelines among overweight and obese women with a normotensive pregnancy or hypertensive disorder of pregnancy. Study design: 315 early pregnant women were enrolled prospectively and followed up to 12 months after delivery (mean 7.0 ± 1.8 months). At a postpartum research visit, we measured blood pressure and collected blood samples to measure cystatin C and high sensitivity C-reactive protein. Results: A total of 254 women had a normotensive pregnancy, 39 had gestational hypertension (12.4%) and 22 had preeclampsia (7.0%). 91 women had hypertension at the postpartum study visit (28.9%). After adjustment for maternal age, BMI, lactation and time postpartum, preeclampsia was associated with an aOR 2.35 (95%CI 1.63–3.41) of development of sustained hypertension and an aOR 3.23 (95%CI 1.56–6.68) of hypertension with abnormal biomarkers compared to women with normotensive pregnancies. Conclusions: We demonstrate a high prevalence of hypertension and abnormal biomarkers associated with hypertensive disorders of pregnancy among overweight and obese women. Our findings support the need for structured follow up and risk reduction in overweight and obese women with hypertensive disorders of pregnancy as early as the first year postpartum.

LanguageEnglish (US)
Pages1-6
Number of pages6
JournalPregnancy Hypertension
Volume15
DOIs
StatePublished - Jan 1 2019

Fingerprint

Postpartum Period
Biomarkers
Hypertension
Pregnancy
Pre-Eclampsia
Obesity
Cystatin C
Pregnancy Induced Hypertension
Maternal Age
Risk Reduction Behavior
Lactation
C-Reactive Protein
Pregnant Women
Cardiovascular Diseases
Guidelines
Blood Pressure
Research

Keywords

  • Cardiovascular disease
  • Chronic hypertension
  • Cystatin C
  • Gestational hypertension
  • HsCRP
  • Preeclampsia

ASJC Scopus subject areas

  • Internal Medicine
  • Obstetrics and Gynecology

Cite this

Risk of hypertension and abnormal biomarkers in the first year postpartum associated with hypertensive disorders of pregnancy among overweight and obese women. / Hauspurg, Alisse; Countouris, Malamo E.; Jeyabalan, Arun; Hubel, Carl A.; Roberts, James M.; Schwarz, Eleanor; Catov, Janet M.

In: Pregnancy Hypertension, Vol. 15, 01.01.2019, p. 1-6.

Research output: Contribution to journalArticle

Hauspurg, Alisse ; Countouris, Malamo E. ; Jeyabalan, Arun ; Hubel, Carl A. ; Roberts, James M. ; Schwarz, Eleanor ; Catov, Janet M. / Risk of hypertension and abnormal biomarkers in the first year postpartum associated with hypertensive disorders of pregnancy among overweight and obese women. In: Pregnancy Hypertension. 2019 ; Vol. 15. pp. 1-6.
@article{337cac0f0772473fb9b075c78504d715,
title = "Risk of hypertension and abnormal biomarkers in the first year postpartum associated with hypertensive disorders of pregnancy among overweight and obese women",
abstract = "Objectives: Hypertension and obesity are common cardiometabolic risk factors in reproductive age women. The association of hypertensive disorders of pregnancy with later-life cardiovascular disease is well-established, however, it is unknown how obesity and hypertensive disorders of pregnancy converge to accelerate development of hypertension in the postpartum period. The aim of this study was to characterize rates of sustained hypertension at one year postpartum using the new American Heart Association/American College of Cardiology Guidelines among overweight and obese women with a normotensive pregnancy or hypertensive disorder of pregnancy. Study design: 315 early pregnant women were enrolled prospectively and followed up to 12 months after delivery (mean 7.0 ± 1.8 months). At a postpartum research visit, we measured blood pressure and collected blood samples to measure cystatin C and high sensitivity C-reactive protein. Results: A total of 254 women had a normotensive pregnancy, 39 had gestational hypertension (12.4{\%}) and 22 had preeclampsia (7.0{\%}). 91 women had hypertension at the postpartum study visit (28.9{\%}). After adjustment for maternal age, BMI, lactation and time postpartum, preeclampsia was associated with an aOR 2.35 (95{\%}CI 1.63–3.41) of development of sustained hypertension and an aOR 3.23 (95{\%}CI 1.56–6.68) of hypertension with abnormal biomarkers compared to women with normotensive pregnancies. Conclusions: We demonstrate a high prevalence of hypertension and abnormal biomarkers associated with hypertensive disorders of pregnancy among overweight and obese women. Our findings support the need for structured follow up and risk reduction in overweight and obese women with hypertensive disorders of pregnancy as early as the first year postpartum.",
keywords = "Cardiovascular disease, Chronic hypertension, Cystatin C, Gestational hypertension, HsCRP, Preeclampsia",
author = "Alisse Hauspurg and Countouris, {Malamo E.} and Arun Jeyabalan and Hubel, {Carl A.} and Roberts, {James M.} and Eleanor Schwarz and Catov, {Janet M.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.preghy.2018.10.009",
language = "English (US)",
volume = "15",
pages = "1--6",
journal = "Pregnancy Hypertension",
issn = "2210-7789",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Risk of hypertension and abnormal biomarkers in the first year postpartum associated with hypertensive disorders of pregnancy among overweight and obese women

AU - Hauspurg, Alisse

AU - Countouris, Malamo E.

AU - Jeyabalan, Arun

AU - Hubel, Carl A.

AU - Roberts, James M.

AU - Schwarz, Eleanor

AU - Catov, Janet M.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objectives: Hypertension and obesity are common cardiometabolic risk factors in reproductive age women. The association of hypertensive disorders of pregnancy with later-life cardiovascular disease is well-established, however, it is unknown how obesity and hypertensive disorders of pregnancy converge to accelerate development of hypertension in the postpartum period. The aim of this study was to characterize rates of sustained hypertension at one year postpartum using the new American Heart Association/American College of Cardiology Guidelines among overweight and obese women with a normotensive pregnancy or hypertensive disorder of pregnancy. Study design: 315 early pregnant women were enrolled prospectively and followed up to 12 months after delivery (mean 7.0 ± 1.8 months). At a postpartum research visit, we measured blood pressure and collected blood samples to measure cystatin C and high sensitivity C-reactive protein. Results: A total of 254 women had a normotensive pregnancy, 39 had gestational hypertension (12.4%) and 22 had preeclampsia (7.0%). 91 women had hypertension at the postpartum study visit (28.9%). After adjustment for maternal age, BMI, lactation and time postpartum, preeclampsia was associated with an aOR 2.35 (95%CI 1.63–3.41) of development of sustained hypertension and an aOR 3.23 (95%CI 1.56–6.68) of hypertension with abnormal biomarkers compared to women with normotensive pregnancies. Conclusions: We demonstrate a high prevalence of hypertension and abnormal biomarkers associated with hypertensive disorders of pregnancy among overweight and obese women. Our findings support the need for structured follow up and risk reduction in overweight and obese women with hypertensive disorders of pregnancy as early as the first year postpartum.

AB - Objectives: Hypertension and obesity are common cardiometabolic risk factors in reproductive age women. The association of hypertensive disorders of pregnancy with later-life cardiovascular disease is well-established, however, it is unknown how obesity and hypertensive disorders of pregnancy converge to accelerate development of hypertension in the postpartum period. The aim of this study was to characterize rates of sustained hypertension at one year postpartum using the new American Heart Association/American College of Cardiology Guidelines among overweight and obese women with a normotensive pregnancy or hypertensive disorder of pregnancy. Study design: 315 early pregnant women were enrolled prospectively and followed up to 12 months after delivery (mean 7.0 ± 1.8 months). At a postpartum research visit, we measured blood pressure and collected blood samples to measure cystatin C and high sensitivity C-reactive protein. Results: A total of 254 women had a normotensive pregnancy, 39 had gestational hypertension (12.4%) and 22 had preeclampsia (7.0%). 91 women had hypertension at the postpartum study visit (28.9%). After adjustment for maternal age, BMI, lactation and time postpartum, preeclampsia was associated with an aOR 2.35 (95%CI 1.63–3.41) of development of sustained hypertension and an aOR 3.23 (95%CI 1.56–6.68) of hypertension with abnormal biomarkers compared to women with normotensive pregnancies. Conclusions: We demonstrate a high prevalence of hypertension and abnormal biomarkers associated with hypertensive disorders of pregnancy among overweight and obese women. Our findings support the need for structured follow up and risk reduction in overweight and obese women with hypertensive disorders of pregnancy as early as the first year postpartum.

KW - Cardiovascular disease

KW - Chronic hypertension

KW - Cystatin C

KW - Gestational hypertension

KW - HsCRP

KW - Preeclampsia

UR - http://www.scopus.com/inward/record.url?scp=85055846656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055846656&partnerID=8YFLogxK

U2 - 10.1016/j.preghy.2018.10.009

DO - 10.1016/j.preghy.2018.10.009

M3 - Article

VL - 15

SP - 1

EP - 6

JO - Pregnancy Hypertension

T2 - Pregnancy Hypertension

JF - Pregnancy Hypertension

SN - 2210-7789

ER -